Society for Family Health (SFH) is a leading non-governmental public health organization in Nigeria, implementing programs in malaria prevention, and treatment, Reproductive Health/Family Planning, HIV & AIDS treatment, primary health care system strengthening, non-communicable diseases, and maternal, newborn, and child health care. SFH ignites the power of health system thinking and market shaping to transform health outcomes.

We are recruiting to fill the position below:

Job Title: Monitoring, Evaluation, Research & Learning (MERL) Advisor

Job ID: sfh-16664
Location: Ilorin, Kwara
Job type: Full-time
Category: Programs
Contract Duration: Fixed Term
Position Required: – Project MERL Adviser, HepC 3 Project

About the Position

• In a career at SFH, you will be the center of making all these happen. You will be joining a team of problem solvers, with real passion to change the world in a fast-paced environment. We are a truly Nigerian-rooted organization with global standards and a diverse workforce.
• We pride ourselves on being open, inclusive, and collaborative — and in providing a work environment that encourages our employees to be their best.
• The HepC3 grant is focused on collating evidence on HCV prevalence and practices among people who inject drugs and to identify research priorities and study designs to evaluate the implementation of Low Dead Space Syringes (LDSS) and Long-Acting Depot Buprenorphine (LADB).
• SFH is looking for talented people with a track record of high performance and a passion for providing healthcare for their community to join our vibrant workforce.

Job Profile

• The Project MERL Adviser will support in developing the protocol for the LDSS and LADB research on the HepC3 grant in Oyo and coordinate the research, implementation, political buy-in, documentation and reporting of the project deliverables in Oyo State.
• He/she will participate in TWG meetings on HepC3, analyze and use data to improve program outcomes.
• He/she will write technical reports, abstracts, and journal publications.
• The individual will also be responsible for overseeing and coordinating all activities relating to Hepatitis C amongst PWIDs at the National and State levels.

Job Role
The successful candidate will perform the following functions:

• Oversee the daily activity of the HEPC3P grant and ensure the implementation of all project deliverables.
• Facilitate the review of the National Database for Viral Hepatitis, specifically for high-risk populations.
• Share monthly, quarterly and annual reports with the Programme Coordinator and the Technical Adviser.
• Write technical reports, abstracts, and journal publications.

Qualifications / Experience

• Minimum of 4 years’ post NYSC experience in research and management of health-related programmes.
• Must be computer literate and proficient in using the Microsoft Office Suite at the minimum. Other computer skills will be of added advantage.
• Experience implementing an HIV/Hepatitis project
• Knowledge of Programme management including conceptualization, budget design, implementation, and evaluation with experience in KP programming as an added advantage.
• Demonstrated ability through previous experience to establish and maintain productive working relationships with a wide network of partners and stakeholders.

Skills and Competencies required:

• Technical knowledge and understanding of specific programmatic areas and comfortable with working with a range of stakeholders.
• Social dialogue and advocacy skills for fostering an enabling environment for programme implementation
• Presentation skills
• Data management and reporting skills.
• Leadership skills
• Technical report writing skills

Behavioural Attributes:

• Organisational skills
• Leadership skills
• Continuous and Innovative learner
• Honesty and integrity
• Resilient, resourceful, optimistic and energetic

Compensation & Benefits
The compensation package for this position is very attractive and designed to attract, motivate and retain talented candidates.

Application Closing Date
11th March, 2024.